[Ciprofloxacin in treatment of common bacterial skin infections. Results of an open study in general practice].
Braun
H
H
Klinischen Forschung Bayer, Schweiz AG, Zürich.
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002939:Ciprofloxacin / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D013557:Switzerland
D000890:Anti-Infective Agents; D002939:Ciprofloxacin